The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the Met receptor tyrosine kinase
Cr. Maroun et al., The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the Met receptor tyrosine kinase, MOL CELL B, 20(22), 2000, pp. 8513-8525
Epithelial morphogenesis is critical during development and wound healing,
and alterations in this program contribute to neoplasia. Met, the hepatocyt
e growth factor (HGF) receptor, promotes a morphogenic program in epithelia
l cell lines in matrix cultures. Previous studies have identified Gab1, the
major phosphorylated protein following Met activation, as important for th
e morphogenic response. Gab1 is a docking protein that couples the Met rece
ptor with multiple signaling proteins, including phosphatidylinositol-3 kin
ase, phospholipase C gamma, the adapter protein Crk, and the tyrosine speci
fic phosphatase SHP-2. HGF induces sustained phosphorylation of Gab1 and su
stained activation of extracellular signal-regulated kinase (Erk) in epithe
lial Madin-Darby canine kidney cells. In contrast, epidermal growth factor
fails to promote a morphogenic program and induces transient Gab1 phosphory
lation and Erk activation. To elucidate the Gab1-dependent signals required
for epithelial morphogenesis, we undertook a structure-function approach a
nd demonstrate that association of Gab1 with the tyrosine phosphatase SHP-2
is required for sustained Erk activation and for epithelial morphogenesis
downstream from the Met receptor. Epithelial cells expressing a Gab1 mutant
protein unable to recruit SHP-2 elicit a transient activation of Erk in re
sponse to HGF. Moreover, SHP-2 catalytic activity is required, since the ex
pression of a catalytically inactive SHP-2 mutant, C/S, abrogates sustained
activation of Erk and epithelial morphogenesis by the Met receptor. These
data identify SHP-2 as a positive modulator of Erk activity and epithelial
morphogenesis downstream from the Met receptor.